India  

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

IndiaTimes Tuesday, 19 January 2021
An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech, official sources said.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Delhi high court asks Serum Institute, Bharat Biotech to disclose capacity to manufacture Covid-19 vaccines

"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So..
IndiaTimes

Covaxin shows 81% efficacy, say ICMR and Bharat Biotech

This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical..
IndiaTimes
Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News [Video]

Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News

Arvind Kejriwal slams BJP saying the party has failed to govern the municipal corporations in Delhi. Karnataka Minister resigns on moral grounds after tape scandal. Maharashtra Chief Minister Uddhav Thackeray slams BJP and RSS. In a statement made by Bharat Biotech, the biotechnology company claims that the Covaxin is 81 percent effective in preventing Covid and can work against the UK variant of the virus. TMC meets Election Commission over PM's photo on vaccine documents #PMModi #ArvindKejriwal #KarnatakaMinisterSexTape

Credit: Oneindia    Duration: 02:43Published
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.

Credit: ANI    Duration: 01:42Published

Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results

Covaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
DNA

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Bash: This is why key GOP senator is fighting Biden's stimulus [Video]

Bash: This is why key GOP senator is fighting Biden's stimulus

CNN’s Dana Bash says that Sen. Ron Johnson (R-WI) is doing everything in his power to delay President Joe Biden’s Covid-19 stimulus relief bill because Johnson believes that fighting Biden’s agenda will help get him reelected.

Credit: Bleacher Report AOL    Duration: 02:18Published
Chris Kamara ‘feeling great’ after getting Covid jab [Video]

Chris Kamara ‘feeling great’ after getting Covid jab

TV presenter Chris Kamara has urged people from black, Asian and minority ethnic (BAME) communities to get the Covid-19 vaccine.The Sky Sports analyst said he was “feeling great” after getting his first jab and hoped it would accelerate a return to normal life.The 63-year-old said he understands why some people in minority communities may be reluctant to have the vaccination, and revealed that his Sierra Leone-born father was hesitant about needles.

Credit: PA - Press Association STUDIO    Duration: 01:40Published
Covid vaccine: Registration & what to expect | Max hospital Saket | Oneindia News [Video]

Covid vaccine: Registration & what to expect | Max hospital Saket | Oneindia News

With the 2nd phase of vaccination being kicked off in India from March 1st, designated inoculation centres are brimming with people waiting to get the jab. We visited Max Smart Super Speciality Hospital in Saket to show you what to expect. #CovidVaccine #MaxHospital #CoWin

Credit: Oneindia    Duration: 04:42Published
LG Anil Baijal, Minister Prahlad Singh take first dose of COVID-19 vaccine [Video]

LG Anil Baijal, Minister Prahlad Singh take first dose of COVID-19 vaccine

As second phase of vaccination of COVID-19 is underway in India, Delhi Lieutenant Governor Anil Baijal took the first dose of COVID-19 vaccine at Tirath Ram Shah Hospital. Union Tourism Minister Prahlad Singh Patel also received the first dose on March 04 in Delhi.

Credit: ANI    Duration: 01:19Published

You Might Like


Related videos from verified sources

See first dose of Johnson & Johnson Covid-19 vaccine being administered [Video]

See first dose of Johnson & Johnson Covid-19 vaccine being administered

The one-dose Johnson & Johnson Covid-19 vaccine is administered in the United States for the first time outside of a clinical trial at a mass vaccination site in Columbus, Ohio.

Credit: Bleacher Report AOL     Duration: 00:43Published
Covid-19 vaccination drive 2.0: PM Modi takes Covaxin shot, what does it mean? | Oneindia News [Video]

Covid-19 vaccination drive 2.0: PM Modi takes Covaxin shot, what does it mean? | Oneindia News

India's second phase of the vaccination drive began today, opening registerations for people above 60 years and those aged 45 in the second phase of the inoculation drive. In the second phase, Prime..

Credit: Oneindia     Duration: 04:14Published
Covid vaccine: How to register, where to go, what you need | All key details [Video]

Covid vaccine: How to register, where to go, what you need | All key details

Phase 2 of India's Covid-19 vaccination drive was launched in high-profile manner on March 1 with Prime Minister Narendra Modi becoming one of the first beneficiaries. The second phase of the programme..

Credit: HT Digital Content     Duration: 04:31Published

Related news from verified sources

'Start vaccination drive only after proper screening'

'Start vaccination drive only after proper screening'
AS India is all set to begin vaccinations against COVID-19, health experts have raised concerns about allergic reactions as a side effect. Allergic reactions to...
Mid-Day

Covid cases, fatality sharply decline in Odisha

Covid-19 positive cases are hovering between 100 and 200 during the last one week. Thirteen people have lost their lives due to Covid in the last two weeks. Only...
IndiaTimes Also reported by •Mid-Day

What you need to know about Oxford COVID-19 vaccine

With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon...
Mid-Day Also reported by •IndiaTimes